Results 11 to 20 of about 124,344 (344)

Mitomycin C in pterygium treatment.

open access: yesInternational Journal of Ophthalmology, 2016
Pterygium is a benign lesion usually growing from the nasal side of the conjunctiva onto the cornea. Most cases of pterygium does not cause problem or requires specific treatment.
T. Martins   +4 more
semanticscholar   +5 more sources

Mitomycins syntheses: a recent update [PDF]

open access: yesBeilstein Journal of Organic Chemistry, 2009
Mitomycins are a class of very potent antibacterial and anti-cancer compounds having a broad activity against a range of tumours. They have been used in clinics since the 1960’s, and the challenges represented by their total synthesis have challenged ...
Jean-Christophe Andrez
doaj   +4 more sources

Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer

open access: yesInternational Journal of Hyperthermia, 2021
Objectives To compare the therapeutic effects of locoregional deep hyperthermia combined with intravesical chemotherapy with those of intravesical chemotherapy alone in patients with intermediate-/high-risk non-muscle invasive bladder cancer (NMIBC).
Yu-Ching Wen   +8 more
doaj   +1 more source

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer

open access: yesBJU International, 2020
To evaluate the activity of intravesical mitomycin‐C (MMC) to ablate recurrent low‐risk non‐muscle‐invasive bladder cancer (NMIBC) and assess whether it may enable patients to avoid surgical intervention for treatment of recurrence.
A. Mostafid   +16 more
semanticscholar   +1 more source

Application of mitomycin in the treatment of cicatricial complications after radical prostatectomy

open access: yesАндрология и генитальная хирургия, 2014
At a choice of a way of treatment of the localized prostate cancer not the last place is occupied by an assessment of possible complications after the executed operation.
Yu. G. Alyaev   +3 more
doaj   +3 more sources

An unusual case of scleral thinning with uveal exposure following pterygium surgery and its management

open access: yesKerala Journal of Ophthalmology, 2021
To report unusual cases of acute onset, complete, non-infected, localized scleral thinning with uveal exposure post pterygium excision and how to manage a case.
Pratima Chavhan   +3 more
doaj   +1 more source

Mitomycin C Inhibits Esophageal Fibrosis by Regulating Cell Apoptosis and Autophagy via lncRNA-ATB and miR-200b

open access: yesFrontiers in Molecular Biosciences, 2021
Benign esophageal strictures (BESs) frequently results from esophageal fibrosis. The transformation of fibroblasts into fibrocyte is an important cause of fibrosis. The treatment of fibrosis is challenging.
Yin Zhang   +17 more
doaj   +1 more source

A retrospective analysis of concurrent chemoradiation for squamous cell carcinoma of the anus in Johannesburg

open access: yesSouth African Journal of Oncology, 2023
Background: Anal cancer is a major cause of mortality and morbidity in low- and middle-income countries (LMICs). Aim: A retrospective analysis to understand presentation and outcomes of patients with anal cancer, who were treated with a curative intent.
Phemelo Tshoeu, Vinay Sharma, Paul Ruff
doaj   +1 more source

Mitosene-DNA adducts. Characterization of two major DNA monoadducts formed by 1,10-bis(acetoxy)-7-methoxymitosene upon reductive activation [PDF]

open access: yes, 1997
Reductive activation of racemic 1,10-bis(acetoxy)-7-methoxymitosene WV15 in the presence of DNA, followed by enzymatic digestion and HPLC analysis, revealed the formation of various DNA adducts.
Duynhoven, John P.M. van   +8 more
core   +2 more sources

Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib

open access: yesBiomedicines, 2022
Recent efforts to personalize treatment with platinum-based chemotherapy and PARP inhibitors have produced promising results in homologous recombinant deficient (HRD) metastatic pancreatic cancer (MPC).
Gehan Botrus   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy